2006. Cost-effectiveness analysis of paclitaxel + carboplatin vs. alternative combinations in the treatment of non-small cell lung cancer. Farmeconomia. Health Economics and Therapeutic Pathways. 7, 2 (Sep. 2006), 97–117. DOI:https://doi.org/10.7175/fe.v7i2.680.